Cargando…
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
BACKGROUND: Ex vivo production of hematopoietic stem/precursor cells (HSPCs) represents a promising versatile approach for blood disorders. METHODS: To derive definitive HSPCs from human embryonic stem cells (ESCs), we differentiated mesodermally specified embryoid bodies (EBs) on gelatin-coated pla...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688003/ https://www.ncbi.nlm.nih.gov/pubmed/33234163 http://dx.doi.org/10.1186/s13287-020-02019-5 |
_version_ | 1783613624771674112 |
---|---|
author | Demirci, Selami Haro-Mora, Juan J. Leonard, Alexis Drysdale, Claire Malide, Daniela Keyvanfar, Keyvan Essawi, Khaled Vizcardo, Raul Tamaoki, Naritaka Restifo, Nicholas P. Tisdale, John F. Uchida, Naoya |
author_facet | Demirci, Selami Haro-Mora, Juan J. Leonard, Alexis Drysdale, Claire Malide, Daniela Keyvanfar, Keyvan Essawi, Khaled Vizcardo, Raul Tamaoki, Naritaka Restifo, Nicholas P. Tisdale, John F. Uchida, Naoya |
author_sort | Demirci, Selami |
collection | PubMed |
description | BACKGROUND: Ex vivo production of hematopoietic stem/precursor cells (HSPCs) represents a promising versatile approach for blood disorders. METHODS: To derive definitive HSPCs from human embryonic stem cells (ESCs), we differentiated mesodermally specified embryoid bodies (EBs) on gelatin-coated plates in serum/feeder-free conditions. RESULTS: Seven-day EB maturation followed by an 8-day differentiation period on OP9 cells provided the highest number of definitive (CD34+ CD235a−, 69%, p < 0.01) and lowest number of primitive (CD34− CD235a+, 1.55%, p < 0.01) precursor cells along with the highest colony-forming units (149.8 ± 11.6, p < 0.01) in feeder-free conditions. Maximal HSPC fraction (CD34+ CD38− CD45RA− CD49f+ CD90+) was 7.6–8.9% after 10 days of hematopoietic differentiation with 14.5% adult β-globin expression following RBC differentiation. Myeloid and erythroid colonies were restricted strictly to the CD34+ CD43+ fraction (370.5 ± 65.7, p < 0.001), while the CD34− CD43+ fraction produced only a small number of colonies (21.6 ± 11.9). In addition, we differentiated the CD34+ CD43+ cells towards T-lymphocytes using the OP9/DLL1 co-culture system demonstrating double-positive T cells (CD4+ CD8+) with CD3+ expression displaying a broad T cell receptor (TCR) repertoire. Confocal imaging of organoid-like structures revealed a close association of CD31+ cells with CD34+ and CD43+ cells, suggesting a potential emergence of HSPCs through endothelial to hematopoietic transition. Furthermore, fluorescently labeled organoids exhibited the emergence of spherical non-attached cells from rare progenitors at the border of the organoid center. CONCLUSIONS: In summary, definitive HSPCs can be derived from ESCs through a dynamic cellular process from an organoid-like structure, where erythroid progeny are capable of producing adult hemoglobin and lymphoid progeny shows a diverse TCR repertoire. |
format | Online Article Text |
id | pubmed-7688003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76880032020-11-30 Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation Demirci, Selami Haro-Mora, Juan J. Leonard, Alexis Drysdale, Claire Malide, Daniela Keyvanfar, Keyvan Essawi, Khaled Vizcardo, Raul Tamaoki, Naritaka Restifo, Nicholas P. Tisdale, John F. Uchida, Naoya Stem Cell Res Ther Research BACKGROUND: Ex vivo production of hematopoietic stem/precursor cells (HSPCs) represents a promising versatile approach for blood disorders. METHODS: To derive definitive HSPCs from human embryonic stem cells (ESCs), we differentiated mesodermally specified embryoid bodies (EBs) on gelatin-coated plates in serum/feeder-free conditions. RESULTS: Seven-day EB maturation followed by an 8-day differentiation period on OP9 cells provided the highest number of definitive (CD34+ CD235a−, 69%, p < 0.01) and lowest number of primitive (CD34− CD235a+, 1.55%, p < 0.01) precursor cells along with the highest colony-forming units (149.8 ± 11.6, p < 0.01) in feeder-free conditions. Maximal HSPC fraction (CD34+ CD38− CD45RA− CD49f+ CD90+) was 7.6–8.9% after 10 days of hematopoietic differentiation with 14.5% adult β-globin expression following RBC differentiation. Myeloid and erythroid colonies were restricted strictly to the CD34+ CD43+ fraction (370.5 ± 65.7, p < 0.001), while the CD34− CD43+ fraction produced only a small number of colonies (21.6 ± 11.9). In addition, we differentiated the CD34+ CD43+ cells towards T-lymphocytes using the OP9/DLL1 co-culture system demonstrating double-positive T cells (CD4+ CD8+) with CD3+ expression displaying a broad T cell receptor (TCR) repertoire. Confocal imaging of organoid-like structures revealed a close association of CD31+ cells with CD34+ and CD43+ cells, suggesting a potential emergence of HSPCs through endothelial to hematopoietic transition. Furthermore, fluorescently labeled organoids exhibited the emergence of spherical non-attached cells from rare progenitors at the border of the organoid center. CONCLUSIONS: In summary, definitive HSPCs can be derived from ESCs through a dynamic cellular process from an organoid-like structure, where erythroid progeny are capable of producing adult hemoglobin and lymphoid progeny shows a diverse TCR repertoire. BioMed Central 2020-11-24 /pmc/articles/PMC7688003/ /pubmed/33234163 http://dx.doi.org/10.1186/s13287-020-02019-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Demirci, Selami Haro-Mora, Juan J. Leonard, Alexis Drysdale, Claire Malide, Daniela Keyvanfar, Keyvan Essawi, Khaled Vizcardo, Raul Tamaoki, Naritaka Restifo, Nicholas P. Tisdale, John F. Uchida, Naoya Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation |
title | Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation |
title_full | Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation |
title_fullStr | Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation |
title_full_unstemmed | Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation |
title_short | Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation |
title_sort | definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688003/ https://www.ncbi.nlm.nih.gov/pubmed/33234163 http://dx.doi.org/10.1186/s13287-020-02019-5 |
work_keys_str_mv | AT demirciselami definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT haromorajuanj definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT leonardalexis definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT drysdaleclaire definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT malidedaniela definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT keyvanfarkeyvan definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT essawikhaled definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT vizcardoraul definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT tamaokinaritaka definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT restifonicholasp definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT tisdalejohnf definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation AT uchidanaoya definitivehematopoieticstemprogenitorcellsfromhumanembryonicstemcellsthroughserumfeederfreeorganoidinduceddifferentiation |